Lord, Abbett & Co’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$118M Buy
609,552
+310,296
+104% +$38.3M 0.35% 73
2026
Q2
$30.8M Buy
299,256
+199,626
+200% +$13M 0.09% 242
2026
Q1
$4.73M Buy
+99,630
New +$4.47M 0.02% 464
2025
Q2
– Sell
-101,298
Closed -$3.98M – 585
2025
Q1
$3.98M Buy
+101,298
New +$4.56M 0.01% 477
2024
Q4
– Sell
-104,426
Closed -$4.72M – 584
2024
Q3
$4.72M Sell
104,426
-249,802
-71% -$11.9M 0.02% 481
2024
Q2
$17.5M Buy
354,228
+52,733
+17% +$2.15M 0.06% 340
2024
Q1
$10.3M Buy
301,495
+86,536
+40% +$3.12M 0.03% 395
2023
Q4
$7.92M Buy
+214,959
New +$4.97M 0.03% 412
2021
Q2
– Sell
-28,504
Closed -$3.53M – 712
2021
Q1
$3.53M Sell
28,504
-412,158
-94% -$62.6M 0.01% 600
2020
Q4
$62.3M Sell
440,662
-113,200
-20% -$12.6M 0.16% 201
2020
Q3
$42.1M Buy
553,862
+239,020
+76% +$14.9M 0.13% 243
2020
Q2
$14.3M Sell
314,842
-36,887
-10% -$1.32M 0.05% 422
2020
Q1
$10.8M Sell
351,729
-203,438
-37% -$5.47M 0.05% 418
2019
Q4
$11.7M Buy
555,167
+75,706
+16% +$1.77M 0.04% 491
2019
Q3
$11.4M Buy
479,461
+124,136
+35% +$3.61M 0.04% 501
2019
Q2
$10.3M Buy
+355,325
New +$9.4M 0.03% 537

Other funds holding TWST

Lord, Abbett & Co's TWST Position: Q3 2026 in Review

Lord, Abbett & Co increased its Twist Bioscience (TWST) stake by 104% in Q3 2026, buying an estimated $38.3M and bringing the position to 609,552 shares worth $118M. The position accounts for 0.35% of the portfolio, ranked #73.

Lord, Abbett & Co first reported a position in TWST in Q2 2019 and has held it in 16 quarters since. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Lord, Abbett & Co held 609,552 shares of Twist Bioscience worth $118M as of Q3 2026.
  • Lord, Abbett & Co bought 310,296 Twist Bioscience shares in Q3 2026, an estimated $38.3M.
  • Twist Bioscience made up 0.35% of Lord, Abbett & Co's portfolio in Q3 2026, its #73 holding.
  • Lord, Abbett & Co first reported a position in Twist Bioscience in Q2 2019 and has held it in 16 quarters since.
  • 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.